Nan Shan Life Insurance Co. Ltd. Grows Holdings in Synopsys, Inc. (NASDAQ:SNPS)

Nan Shan Life Insurance Co. Ltd. grew its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 2.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 89,155 shares of the semiconductor company's stock after purchasing an additional 1,967 shares during the period. Nan Shan Life Insurance Co. Ltd. owned approximately 0.06% of Synopsys worth $43,272,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in SNPS. NorthRock Partners LLC purchased a new stake in Synopsys during the 4th quarter worth approximately $640,000. Nuveen Asset Management LLC raised its holdings in shares of Synopsys by 12.1% in the fourth quarter. Nuveen Asset Management LLC now owns 1,691,501 shares of the semiconductor company's stock worth $820,987,000 after buying an additional 182,115 shares during the last quarter. OMERS ADMINISTRATION Corp lifted its stake in shares of Synopsys by 54.7% during the fourth quarter. OMERS ADMINISTRATION Corp now owns 310,616 shares of the semiconductor company's stock worth $150,761,000 after buying an additional 109,785 shares during the period. Obermeyer Wealth Partners grew its holdings in shares of Synopsys by 3.6% during the fourth quarter. Obermeyer Wealth Partners now owns 890 shares of the semiconductor company's stock valued at $432,000 after buying an additional 31 shares during the last quarter. Finally, Maytus Capital Management LLC acquired a new position in shares of Synopsys in the 4th quarter valued at $485,000. Institutional investors and hedge funds own 85.47% of the company's stock.

Synopsys Stock Up 0.0%

Shares of SNPS stock traded up $0.22 during trading hours on Monday, hitting $514.65. 219,853 shares of the company's stock were exchanged, compared to its average volume of 1,104,419. The firm has a 50 day moving average of $444.44 and a two-hundred day moving average of $488.96. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $624.80. The firm has a market cap of $79.57 billion, a P/E ratio of 35.44, a P/E/G ratio of 3.23 and a beta of 1.16.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on SNPS. Wells Fargo & Company lowered their price target on Synopsys from $540.00 to $520.00 and set an "equal weight" rating for the company in a research report on Thursday, February 27th. Piper Sandler reduced their price objective on Synopsys from $655.00 to $653.00 and set an "overweight" rating for the company in a research note on Thursday, February 27th. Needham & Company LLC reiterated a "buy" rating and issued a $650.00 target price on shares of Synopsys in a research report on Thursday, February 27th. Rosenblatt Securities reiterated a "buy" rating and issued a $660.00 price target on shares of Synopsys in a report on Tuesday, February 25th. Finally, KeyCorp decreased their price objective on shares of Synopsys from $690.00 to $555.00 and set an "overweight" rating for the company in a research note on Tuesday, April 15th. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $613.43.

Insider Buying and Selling at Synopsys

In other Synopsys news, insider Geus Aart De sold 15,705 shares of the stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the completion of the transaction, the insider now owns 116,671 shares of the company's stock, valued at $51,850,925.82. This represents a 11.86% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $463.75, for a total value of $5,270,982.50. Following the completion of the transaction, the chief executive officer now directly owns 70,922 shares of the company's stock, valued at approximately $32,890,077.50. This represents a 13.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.62% of the company's stock.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.